Skip to main content

Daclizumab beta may be superior to interferon beta on MS disability progression

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Daclizumab beta may be superior to interferon beta on MS disability progression

User login

Username

Password

Reset your password

Type	Lead	score